## TGT: Target Corporation - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_20 0.7% below STRENGTH zone (4.0-10.0%); PEG 2.81 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($86.27)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. Target Corporation (NYSE:TGT) Given Consensus Rating of "Hold" by Brokerages**
- Source: MarketBeat | 20251204T070819 | Neutral | Relevance: 100%
- Target Corporation (NYSE:TGT) has received a consensus "Hold" rating from 36 brokerage firms, with an average 12-month price target of $102.79. The company reported EPS of $1.78, beating estimates, but revenue of $25.27 billion missed expectations and declined year-over-year. Target also raised its quarterly dividend to $1.14, resulting in a 5.0% yield, and institutional investors hold approximately 79.73% of the stock.

**2. Target (NYSE:TGT) Price Target Cut to $125.00 by Analysts at Argus**
- Source: MarketBeat | 20251202T135348 | Somewhat-Bearish | Relevance: 100%
- Argus has cut its price target for Target (NYSE:TGT) to $125 from $135, while maintaining a "buy" rating, indicating a potential 37.6% upside. Despite this, the broader analyst consensus for Target is a "Hold" with an average price target of $102.79. The company recently reported Q3 EPS of $1.78, beating estimates, but revenue slightly missed expectations and FY2025 EPS guidance is below sell-side forecasts.

**3. Korea Investment CORP Sells 260,029 Shares of Target Corporation $TGT**
- Source: MarketBeat | 20251202T120631 | Neutral | Relevance: 100%
- Korea Investment CORP significantly reduced its stake in Target Corporation by selling 260,029 shares in Q2, decreasing its holdings by 66.3% to 132,277 shares valued at $13.05 million. Despite this, other institutions like Charles Schwab and Vanguard increased their exposure to Target. Analyst ratings for Target are predominantly "Hold," with an average price target of $102.00, and the company recently raised its quarterly dividend to $1.14 per share, offering a 5.0% yield.

**4. Read This Before Buying Target Stock**
- Source: www.sharewise.com | 20251202T032148 | Somewhat-Bearish | Relevance: 100%
- Target stock has seen a significant decline over the past few years, with its stock diving and trading at a low price-to-earnings ratio. The company is struggling due to its core customers cutting back on discretionary spending amidst high inflation, impacting sales and earnings. Revenue and comparable sales were down in the 2025 fiscal third quarter, leading to a decrease in EPS.

**5. Target and Dr. Squatch Introduce Kris K. from Target's Limited-Edition "Not Santa" Soap**
- Source: Barchart.com | 20251204T110919 | Bullish | Relevance: 100%
- Target and Dr. Squatch have collaborated to release a limited-edition "Not Santa" soap, starring Kris K. from Target, the viral holiday sensation. The sandalwood-scented soap, made with over 98% natural origin ingredients, launches nationwide on December 7th for $7.99. This partnership aims to extend the joy and humor of Kris K.'s holiday mission into consumers' homes, offering an affordably awesome gift for various recipients.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 12)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-01 | Argus Research | $125 | $135 | -7% |
| 2025-11-20 | Citigroup | $89 | $100 | -11% |
| 2025-11-20 | Roth Capital | $88 | $90 | -2% |
| 2025-11-20 | Piper Sandler | $85 | $94 | -10% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-01 | Argus Research | main | Buy |
| 2025-11-20 | Citigroup | main | Neutral |
| 2025-11-20 | Roth Capital | reit | Neutral |
| 2025-11-20 | Piper Sandler | reit | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 2 ($0.66M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.3% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.8% (+12.6%)
- State Street Corpora: 8.3% (+2.5%)
- Blackrock Inc.: 7.7% (+2.8%)
- Charles Schwab Inves: 3.6% (+1.6%)
- FMR, LLC: 3.2% (+5.1%)

### Key Risks

1. Long-term trend broken: trading 6.4% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.81 signals overvaluation risk, limited margin of safety. Forward P/E 11.9x stretched relative to 5% growth. Quality metrics strong (ROE 25%). Analyst sentiment negative (12 target cuts vs 2 raises). Institutional flow bearish (3 selling vs 6 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $45.2B |
| Beta | 1.12 |
| 52W Range | $83.44 - $145.08 |
| Short Interest | 4.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.81 |
| Forward P/E | 11.9 |
| Current P/E | 12.5 |
| YoY Growth | 5.1% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at 0.7% (minimal 5-day change). Below STRENGTH zone by 3.3pp (needs >4.0% for momentum thesis). MRS_5 at 0.2% confirms short-term momentum alignment. Below SMA200 (0.94x), long-term trend not supportive. RSI neutral at 54. OFD pattern: +SBN (Volatile).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.74% (CS: 59) | Neutral |
| RSI_14 | 54.3 | Neutral |
| MACD Histogram | 0.50 | Bullish |
| vs SMA20 | 1.026x | Above |
| vs SMA50 | 1.014x | Above |
| vs SMA200 | 0.936x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $91.59
- **Stop Loss:** $86.27 (5.8% risk)
- **Target:** $96.91 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 93
- **Position Value:** $8,517.87
- **Portfolio %:** 8.52%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at 15.78 indicates calm conditions but breadth at 53% suggests narrow participation. Fed policy remains neutral with 42 days to next meeting, supporting steady positioning with sector selectivity.*

### Earnings

**Next:** 2026-03-04 (Est: $2.25)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $1.71 | $1.78 | +4.1% |
| 2025Q3 | $2.03 | $2.05 | +0.8% |
| 2025Q2 | $1.65 | $1.30 | -21.3% |
| 2025Q1 | $2.25 | $2.41 | +7.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*